Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use DAXXIFY safely and effectively. See full prescribing information for DAXXIFY. DAXXIFY ®(daxibotulinumtoxinA-lanm) for injection, for intramuscular useInitial U.S. Approval: 2022
Medication labelWhy this: Advisory · dailymed-prescription
DAXXIFY is indicated for the temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity in adult patients. DAXXIFY is indicated for the treatment of cervical dystonia in adult patients.
- generic_name
- botulinum toxin type a
- product_names
- botulinum toxin type A
- ndc
- 72960-112, 72960-112-01, 72960-112-02, 72960-112-05, 72960-112-06
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en